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Abstract
Background: Diabetic nutritional treatment involves the discussion of Low Carbohydrate Diet (LCD) 
and Calorie Restriction (CR). Authors have initiated and developed LCD in Japan and continued clini-
cal research. In this study, we investigated glucose variability in patients with type 2 diabetes mellitus 
(T2DM). Subjects and Methods: Subjects were 60 T2DM patients of 62.7 years in average with its 
fasting immunoreactive insulin (IRI) less than 5μU/mL. Methods include basal blood test, daily profile 
of blood glucose and insulinogenic index (IGI) for 70g of carbohydrate (0-30min) in CR breakfast. 
Correlation among these and comparison in 4 groups categorized by Morbus value were analyzed. 
Results: Basal data revealed HbA1c 7.9%, daily glucose 222 mg/dL in average, and Triglyceride 83 
mg/dL, Morbus value 150, HOMA-R 1.1, HOMA-β 11.0 in median. Delta Ratio of IGI and AUC ratio 
of IGI showed significant correlations with M value and HbA1c (p<0.01). Discussion and Conclusion: 
Meal Tolerance Test (MTT) has been recently used for convenient methods and meaningful results. 
AUC ratio suggests a little superior than Delta ratio for its higher correlation coefficient. These results 
would become the basal data in this field, and further development of related research is expected in 
the future. 
Keywords: area under the curves (AUC), insulinogenic index (IGI), type 2 diabetes mellitus (T2DM), 
morbus value (M value), delta ratio of IGI, AUC ratio of IGI
          As to diabetes mellitus, the prevalence of diabetes has 
been increasing worldwide, and it would become not only 
medical problem, but also social, economic and ecological 
problems [1]. Diabetes has a variety of complications with 
micro-angiopathy and macro-angiopathy. The former 
includes neuropathy, retinopathy and neuropathy, and 
furthermore, the latter includes large vessels impairment 
and dysfunction of head, heart and lower leg [2].
         For diabetic prevention and treatment, several diabet-
ic societies have presented their guidelines until now. 
There was recently the proposal of changes in the guide-
line about the goal of treatment for diabetes. American 
Diabetes Association (ADA) has given the comments in 
2017 [3], which was followed by the joint algorithm of 
European Diabetes Society (EASD) 2012 [4]. In succes-
sion, American College of Physicians (ACP) has 
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proposed the change in standard value concerning the goal 
of HbA1c value [5], where the management goal for 
HbA1c in most type 2 diabetic patients would be 7% or 
more and less than 8%. This seemed to be a large impact 
for several diabetic societies. Against the concept of ACP, 
ADA made an objection comment immediately [6]. Thus, 
diabetic management has been in discussion among sever-
al guidelines from medical societies, leading to better clini-
cal practice with accumulated evidences.
         For years, the problem about carbohydrate intake has 
been continued. Diabetic nutritional treatment can be 
generally classified into 2 representative groups One is 
Calorie Restriction (CR) diet, and another is Low Carbo-
hydrate Diet (LCD) [7,8]. The former means mainly the 
restriction fat and calorie restriction, while the latter means 
reduced amount of carbohydrate. LCD has been known for 
clinical effects such as weight reduction and several bene-
ficial aspects. 
        Originally, LCD was started by Atkins and others in 
North American region and European countries [9]. After 
that, authors and colleagues started to introduce LCD 
projects in Japan and developed LCD through lots of 
books, seminars, presentation in medical conferences and 
papers [10,11]. We also developed social movement 
through Japan Low Carbohydrate Diet Promotion Associa-
tion [10]. We have continued clinical practice for diabetes 
with three useful LCD formula meals, which are petit 
LCD, standard LCD, super LCD) [11]. Furthermore, we 
already presented various research reports concerning 
LCD, M value, ketone bodies and related investigation 
[12-14]. 
          As we have continued diabetic research using LCD 
and CR, we have reported the proposal for clinically new 
index which is simple and useful method. It has been simi-
lar method and calculation of insulinogenic index (IGI) 
against 75g oral glucose tolerance test (75gOGTT). 
Subjects have breakfast with 70g of carbohydrate, fat and 
protein in it, which is one of the meal tolerance test (MTT). 
Furthermore, the response of blood glucose and immuno-
reactive insulin (IRI) would be measured [15]. It is called 
insulinogenic index (IGI)-Carbohydarate70g (IGI-Car-
bo70), and seems to play a role of simple and useful clini-
cal diabetic practice. We develop this evaluation method, 
and continue further investigation concerning IGI and 
average glucose, M value and measurement of Delta 
(increment) ratio and Area Under the Curves (AUC) ratio 
of IGI in this study.
Subjects and Methods
        Subjects enrolled in this study were 60 patients with 
type 2 diabetes mellitus (T2DM). For evaluation and treat-
ment for T2DM, they were admitted to the hospital. We 
have performed the standard diabetic examination protocol 
for CR and LCD program. Regarding the necessary 
elements and condition of the patients, the following 
items were included. i) medical diagnosis was T2DM, ii) 
type 1 diabetes mellitus (T1DM) and special type of DM 
were excluded, iii) patients who had already have insulin 
therapy were excluded, iv) patients whose body mass 
index (BMI) was 35 and more than 35 were excluded, v) 
patients whose IRI level was 5 and more than 5 μU/mL 
were excluded.
         Methods for the study were according to our exam-
ination protocol for diabetes with the meal of CR and 
LCD. In this study, the following procedures were used.
Morbus value 
          As one of the biomarker for indicating average blood 
glucose level and also the mean amplitude of glycemic 
excursions (MAGE), M value has been introduced 
[17,18]. Consequently, M value suggests the degree of 
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In regard to research protocol, patients are to take 
the standard meal of CR on day 1 and 2, and LCD 
after day 3, with 1400 kcal/day each. In the case of 
current study, we used the data of meal tolerance 
test (MTT) in the morning of day 2, and the data of 
daily glucose profile 7 times a day on day 2.
In the morning of day 2 after overnight fasting, 
fundamental biomarkers related to diabetes were 
measured. They included glucose, HbA1c, IRI, 
complete blood count, liver and kidney function, 
lipids and so on. 
On day 2 just after drawing blood samples for basal 
items, patients were to take breakfast of standard 
formula. It included 70g of carbohydrate, protein 
and fat. As to this breakfast of CR, PFC ratio was 
15% of protein, 25% of fat and 60% of carbohy-
drate. The content of this standard meal was due to 
the standard guideline of diabetes meal that was 
proposed by Japan Diabetes Society (JDS) [16]. 
The content of the breakfast was calculated as 
follows: The meal has 1400 kcal/day and the ratio 
of the carbohydrate is 60%, then 840 kcal was from 
the carbohydrate per day. One third of 840 kcal is 
280kcal, and 280kcal of carbohydrate equals to 70g 
of carbohydrate as a breakfast.
MTT was performed in the following: Pre and post 
30 min of breakfast, blood sample was drawn for 
blood glucose and IRI. After breakfast for 30 
minutes, the subjects were indicated to keep still on 
the chair on sitting position.
The examination of daily profile of blood glucose 
was done during Day 2. Blood samples were drawn 
7 times a day. They were 0800, 1000, 1200, 1400 
1700, 1900, 2200h. From these results, average 
blood glucose value and also Morbus (M) value 
were obtained using the standard formula calcula-
tion for M value.
(i)
(ii)
(iii)
(iv)
(v)
(vi)
Am J Diabetes Res 2018,1:1
American Journal of Diabetes Research
103
[17,18]. Consequently, M value suggests the degree of 
hyperglycemia and also the degree of high fluctuation or 
swinging of blood glucose in a day. The data of M value 
has been calculated by the way of logarithmic transforma-
tion. It can suppose the deviation of glucose level and 
swinging level from ideal glucose level [17-19]. The level 
of M value is calculated by the method of logarithmic 
transformation, which means the deviation of glucose from 
ideal glucose value [17-19].
         There is the formula to calculate the M value in the 
following way. At first, the basic equation is that M = MBS 
+ MW, and M value is the total of MBS and MW. Second-
ly, MW is (maximum blood glucose − minimum 
glucose)/20. Moreover, MBS is the mean of MBSBS. 
When these equations are summarized, MBSBS is the 
individual M-value for each blood glucose, calculated as 
(absolute value of [10 × log (blood glucose level/120)])3 
[17-20].The result of M value has been clinically evaluated 
as follows: normal range is less than 180, borderline is 
from 180 to 320, abnormal levels are from 180 to 320.
Insulinogenic index for MTT
         According to the results of glucose and IRI on 0 and 
30 min in the MTT, two kinds of IGI were calculated. In 
the case of 75gOGTT, IGI has been indicated to speculate 
pancreas function by the ability of secretion of insulin. The 
formula is that the increment (delta) of insulin (30min – 0 
min) / increment (delta) of blood glucose (30min – 0min). 
In this article, it equals to the ‘Delta Ratio of IGI for 
Carbo70’.
          We tried another evaluating method, taking the advan-
tage of the Area Under the Curves (AUC) describing the 
responses of glucose and insulin. By comparing the area 
size, we call the ratio between IRI and glucose as the ‘AUC 
Ratio of IGI for Carbo70’. To summarize the both calcula-
tion methods, two biomarkers were as follows: the Delta 
Ratio of IGI for Carbo70 is defined as (IRI at 30min – IRI 
at 0min) (μU/mL) / (Glucose at 30min – Glucose at 0min) 
(mg/dL). On contrast, the AUC Ratio of IGI for Carbo70 is 
defined as (AUC of IRI for 0-30min) (μU/mL x h)/ (AUC 
of glucose for 0-30min) (mg/dL x h). 
Glucose variability of a day
         Regarding to the daily profile of blood glucose, 7 
times of blood samples were drawn on day 2. From the 
obtained data, average blood glucose on day 2, and M 
value were investigated. According to the previous study, 
there were almost the similar data of comparison between 
7-times sampling and 20 times sampling [19,20].
Statistical analysis
        In current study, data were revealed by mean and 
standard deviation, and also by the median and quartile of 
25% / 75% in several biomarkers. The latter are described 
as median [25%–75%] inserted numerical value in the 
parenthesis. With regard to the statistical calculation, the 
correlation coefficients were used for the study, in which 
Spearman test has been utilized on analytical evaluation 
[21].
Ethical Standard
          This research was conducted in compliance with the 
ethical principles based upon the Declaration of Helsinki. 
In addition, additional commentary was done in 2004 
General Assembly Tokyo, Japan. These were conducted 
with Personal Information Protection Law and in refer-
ence to “Standards for the Implementation of Clinical 
Trials (GCP), an ordinance of the Ministry of Health, 
Labour and Welfare No. 28 of March 27, 1997. Further-
more, there was the “Ethical Guidelines for Epidemiology 
Research” presented by the Ministry of Education, 
Culture, Sports, Science and Technology and the Ministry 
of Health, Labour and Welfare. 
       Authors and colleagues had an ethical committee 
consisting of professionalisms, such as physician, nurse, 
pharmacist and other experts in the legal specialty. We 
have discussed enough and confirmed that current study 
is valid and agreed with all members. We have obtained 
informed consents and written paper agreements from the 
subjects. Current study was registered by National 
University Hospital Council of Japan (ID: 
#R000031211).
Results
Basal data
          Several data of the subjects in the morning on Day 
2 were shown in Table 1. There were average data about 
62.7 years in age, 7.9% in HbA1c, 222 mg/dL in glucose, 
respectively. There were median data about 150 in M 
value, 1.1 in HOMA-R, 82.5 mg/dL in Triglyceride, 
respectively. 
            Responses of Glucose and insulin for Carbo70 were 
shown in Table 2. From the data of 0 min and 30 min, 
Delta Ratio of IGI for Carbo70 and AUC ratio of IGI for 
Carbo70 were 0.12 [0.07–0.21] and 3.1 [2.3-4.6], respec-
tively. 
Correlation between IGI and M value
            IGI was calculated by 2 methods, one is Delta Ratio 
of IGI for Carbo70, and another is AUC Ratio of IGI for 
Carbo70. There was significant correlation between Delta 
Ratio of IGI for carbo70 and M value (p<0.01) (Figure 
1a). Similarly, there was significant correlation between 
AUC Ratio of IGI for carbo70 and M value (p<0.01) 
(Figure1b). Compared the both, the latter showed higher 
correlation coefficient, with the results of R2 = 0.16 vs 
0.45, respectively. 
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Table 1. Subjects and basal data.
Table 2. Responses of Glucose and insulin for Carbo70
  Mean±SD Median [25% - 75%] 
Subjects Number (M/F) 
age (years old) 
60 (35/25) 
62.7±10.6 
60 (35/25) 
65[59-69] 
Glucose profile HbA1c (%) 
fasting glucose (mg/dL) 
average glucose (mg/dL) 
Morbus value 
7.9±1.7 
168±54.5 
222±82.1 
264±296 
8.0[6.5-9.2] 
156[117-209] 
210[150-281] 
150[40-410] 
Insulin resistance fasting glucose (mg/dL) 
Fasting IRI 
HOMA-R 
HOMA-β 
166±53.9 
2.9±1.1 
1.2±0.6 
13.3±9.1 
156[117-208] 
3.0[2.3-3.9] 
1.1[0.8-1.6] 
11.0[7.3-16.6] 
Lipid profile Triglyceride (mg/dL) 
HDL-C (mg/dL) 
LDL-C (mg/dL) 
LDL/HDL ratio 
115±87.0 
71.1±19.8 
133±38.2 
2.0±0.7 
82.5[60.7-143] 
66.5[568-82.8] 
136[107-157] 
1.8[1.3-2.5] 
Renal function Creatinine (mg/dL) 
Uric Acid (mg/dL) 
Ccr (ml/min) 
Ccr (L/day) 
0.72±0.15 
4.9±1.2 
94.3±25.2 
135±35.9 
0.72[0.62-0.79] 
4.8[4.0-5.6] 
94.0[78.3-109] 
134[112-153] 
  Mean±SD Median [25% - 75%] 
Response of glucose before (0 min) 
after (30 min) 
delta (0-30 min) 
168±54.5 
218±61.8 
51.9±27.8 
156[117-209] 
210[165-271] 
46[32-64] 
Response of Insulin before (0 min) 
after (30 min) 
delta (0-30 min) 
2.9±1.1 
10.2±7.7 
7.4±7.5 
3.0[2.3-3.9] 
8.7[6.3-11.9] 
5.4[3.6-8.8] 
Delta Ratio of IRI/Glu Delta of glucose 
Delta of insulin 
Delta of Ratio 
51.9±27.8 
7.4±7.5 
0.17±0.19 
46[32-64] 
5.4[3.6-8.8] 
0.12[0.07-0.21] 
AUC Ratio of IRI/Glu AUC of glucose 277±83.2 263[201-349] 
Correlation between IGI and HbA1c
       There was significant correlation between Delta Ratio 
of IGI for carbo70 and HbA1c (p<0.01) (Figure 2a). Simi-
larly, there was significant correlation between AUC Ratio 
of IGI for carbo70 and HbA1c (p<0.01) (Figure 2b). Com-
pared the both, the latter showed higher correlation coeffi-
cient, with the results of R2 = 0.16 vs 0.30, respectively.
 
Comparison of M value and HbA1c in 4 groups
          Subjects (N=60) were classified into 4 groups accord-
ing to the data of M value (n=15, each). M value in median 
in the 4 group was 15, 77, 227, 625, respectively (Figure 
3a). HbA1c value was shown in Figure 3b.
Comparison of IGI in 4 groups
           Grouping was performed due to M value and each 
group has 15 cases. IGI are calculated by 2 ways. One is 
Delta Ratio of IGI for Carbo70, and another is AUC Ratio 
of IGI for Carbo70. The result of the former was 0.18, 
0.13, 0.12, 0.07 in median, respectively (Figure 4a). The 
result of the latter was 5.0, 3.9, 2.9, 1.9, respectively 
(Figure 4b). In comparison with the former, the latter that 
is AUC ratio of IGI for Carbo70, showed decreasing 
tendency value from group 1 to group 4.
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Figure 1. Correla�on between Delta/AUC Ra�o and M value. 1a: Correla�on between Delta Ra�o of IGI and M value. 
1b: Correla�on between AUC Ra�o of IGI and M value.
Figure 2. Correla�on between Delta/AUC Ra�o and HbA1c. 2a: Correla�on between Delta Ra�o of IGI and HbA1c. 2b: 
Correla�on between AUC Ra�o of IGI and HbA1c.
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Figure 3. Comparison of M value and HbA1c in 4 groups. 3a: Comparison of M value in 4 groups. 3b: Comparison of 
HbA1c in 4 groups.
Figure 4. Comparison of Delta Ra�o and AUC Ra�o in 4 groups. 4a: Comparison of Delta Ra�o of IGI in 4 groups. 4b: 
Comparison of AUC Ra�o of IGI in 4 groups.
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Discussion
       Discussion on CR and LCD has been continued for 
years. In this perspective, authors have reported clinical 
research in two axes. As the first axis, standard meals of 
CR and LCD were provided and related biomarkers were 
measured and compared. Among these research, M value 
has been calculated which indicates average blood glucose 
and the degree of glucose fluctuation [15,22]. As the 
second axis, breakfast with 70g of carbohydrate from the 
standard CR meal has been tried for the response of 
glucose and insulin. This is one of the MTT similar to 
75gOGTT [15,23,24]. 
          Recently, MTT has been used more for the evaluation 
of pancreas function. Breakfast has been frequently 
applied, in which mixed macronutrients are included 
[25,26]. As an example, there are carbohydrate 50%, fat 
35%, protein 15%, 450 kcal, including 56g of carbohydrate 
[25,26]. 
        From two axes mentioned above, this study is the com-
bination of the both. Daily profile of blood glucose and M 
value represent glucose variability in a day [22,27,28]. 
Furthermore, Delta or AUC ratio of IGI suppose the insulin 
secretion for 30 min. Consequently, this study would be 
related with the pathophysiological background of T2DM. 
The distribution of the data in M value was larger than that 
of HbA1c, suggesting that M value may be more useful 
with less overlap area than HbA1c, and that M value has 
benefit of indicating of both average glucose and mean 
amplitude of glycemic excursions (MAGE) into one 
numerical value [22,27,28]. 
          In 60 cases of this study, median fasting blood glucose 
was 156 mg/dL, and the median average blood glucose was 
210 mg/dL. The 7-times sampling method has reported to 
be the same result of 20-times sampling and continuous 
glucose monitoring (CGM). Probably, CGM will certainly 
be frequently used to the future, but at present this method 
is simple and useful for grasping blood glucose variability.
        In this study, the median increase of glucose and IRI 
increase for Carbo70 were 46 mg/dL and 5.4 μU/mL, 
respectively. The Delta Ratio of IGI for Carbo 70 values 
were 0.17 on average and 0.12 in median. Regarding this 
numerical value, there is a previously related reports. 
       There was similar MTT report by Cozma et al. in which 
formula breakfast has 500 kcal in calorie and 55% of 
carbohydrate [29]. It contains 69g of carbohydrate, which 
is similar to our protocol with 70g of carbohydrate. Due to 
their protocol, they excluded the cases whose fasting 
glucose was more than 180 mg/dL, because of little insulin 
responses. Calculated from the data of Cozma et al. [29], 
supposed data of Delta ratio of IGI is 0.39, and AUC ratio 
of IGI is 12.3, which was similar to our results of those in 
group 1 and 2. Both data are similar in the carbohydrate 
loading 69g vs 70g, and in the insulinogenic index.
        The correlation with M value was compared between 
Delta ratio and AUC ratio. Significant correlation was 
observed in both cases, but higher correlation was found 
in the latter as R2 = 0.45. The reason is speculated to the 
large variance in the Delta calculation method.
          Similarly for the correlation with HbA1c, both Delta 
ratio and AUC ratio were compared. The latter showed a 
higher correlation as R2 = 0.30. This would be probably 
due to wider distribution. Furthermore, compared with M 
value and HbA1c, the correlation of HbA1c with Delta 
and AUC ratio is lower in the latter. M value is calculated 
from the average blood glucose of the day examined, 
while HbA1c is assumed to be the average over the past 
month. These situation would be involved in the differ-
ence between M value and HbA1c.
        As for 4 groups, HbA1c data tended to overlap each 
other, whereas the M value showed little overlap. This is 
probably from the fact that M value indicates average and 
fluctuation of glucose, which would be considered to 
show larger difference in the numerical value. 
       In the study of 4 groups, Delta ratio and AUC ratio 
were compared. In the former, the median value over-
lapped, but in the latter, the median value decreased in the 
group from 1 to 4. Accordingly, in the 4th groups with 
high average blood glucose, the decrease in insulin secre-
tion ability is obviously recognized. It seems to be clearer 
in AUC ratio rather than delta ratio. Consequently, AUC 
ratio seems to be a little superior to Delta ratio as an 
analysis method of IGI.
        In the clinical setting from now on, meal tolerance 
test (MTT) using Carbo 70g can be applied instead of 75g 
OGTT. Moreover, calculation method includes both delta 
ratio and AUC ratio. From current results, AUC ratio may 
be useful for clinical diabetic research, associated with 
assessment way for grouping. 
       There are several methods to suppose insulin response 
to carbohydrate loading in order to examine pancreatic 
function [30]. Conventionally, Intravenous Glucose 
Tolerance Test (IVGTT) and OGTT have been prevalent 
[31. In recent years, MTT has been introduced and adopt-
ed in clinical practice and research.
        There are some reports of MMT. One formula meal 
is high-protein Boost-HP (237ml, Vevey, Switzerland) 
consisting of carbohydrate 33g, protein 15g, fat 6g [32]. 
Its PFC ratio is 25:20:55, and speculated Delta IGI for 
Carbo 33g would be 1.6 in average. Another formula for 
MMT is a breakfast with 450 kcal and PFC = 15:35:50 
[33]. In this case, carbohydrate dose seemed to be 56g in 
the breakfast.
       Recent study showed 2 types of formula breakfast. 
One is carbo-breakfast with PFC = 15:20:65%, and anoth-
er is protein-breakfast with PFC = 35: 20: 45% [34]. 
When same lunch were provided to carbo-group and 
protein-group, the latter showed higher insulin response 
and lower glucose increase. This is called ‘second-meal 
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phenomenon’, keeping the glucose variability controlled.
      By the ingestion of mixed meal loading, GLP-1-in-
duced insulin secretion has been observed [35]. For 
preload of mixed nutrient, glucose tolerance was decreased 
according to the severity level of T2DM [36]. From these, 
to study the responses to nutrient ingestion would clarify 
the pathophysiological function of T2DM, leading to 
improvement of glucose variability.
         There are limitation of this study. Various research due 
to MTT have been found. Because the content has complex 
macronutrients, they may have unstable speed and degree 
of digestion and absorption, various kinds of mixture ratio 
or unexpected response of insulin secretion. However, our 
current research would become a fundamental data for 
future research.
Conclusion
        In summary, we investigated 60 T2DM patients for the 
daily profile of blood glucose, average glucose and 
Morbus value. Furthermore, we studied IGI of insulin/glu-
cose (0-30min) for Carbo70 and calculated the Delta Ratio 
of IGI for Carbo70 and the AUC Ratio of IGI for Carbo70. 
Obtained data were compared and correlations among 
those were investigated. AUC Ratio of IGI seemed to be a 
little superior for clinical research than Delta Ratio of IGI. 
These results would be the basal data in this field, and 
further development of related research is expected in the 
future. 
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Abbreviation
        AUC: Area Under the Curve; IGI: Insulinogenic Index; 
T2DM: Type 2 diabetes mellitus; M value: Morbus value; 
IRI: imuunoreactive insulin
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